BIOA · BioAge Labs, Inc.

$22.81 +0.65 (+2.93%) At close · Jul 17

Market Cap

$1.01B

44,452,734

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Kristen Fortney	CEO	$600,000	—	—	$1,941,390	$330,000	$15,200	$2,886,590
Paul Rubin	Chief Medical Officer	$520,200	—	—	$732,600	$208,080	$15,200	$1,476,080
Eric Morgen	COO	$499,600	—	—	$732,600	$199,840	$15,200	$1,447,240

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Kristen Fortney	CEO	$520,994	—	—	$11,482,514	$208,398	$15,000	$12,226,906
Eric Morgen	COO	$457,657	—	—	$1,832,510	$160,180	$15,000	$2,465,347
Paul Rubin	Chief Medical Officer	$488,139	—	—	$1,249,853	$170,849	$15,000	$1,923,841

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Kristen Fortney	CEO	$493,271	—	—	$626,169	$246,635	$14,400	$1,380,475
Eric Morgen	COO	$435,686	—	—	$232,099	$190,613	$14,400	$872,798
Paul Rubin	Chief Medical Officer	$468,939	—	—	$148,262	$205,161	$14,400	$836,762

Key facts CIK 1709941 CUSIP 09077V100 13F (30d) 8 filings 8 filers Visit website Investor relations